Current use of imatinib in the treatment of chronic myeloid leukemia

被引：0

|

作者：

O'Dwyer, M ^{[1
]}

机构：

[1] Univ Coll Hosp Galway, Dept Hematol, Galway, Ireland

来源：

HAEMATOLOGICA | 2003年 / 88卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：241 / 244

页数：4

相关论文

共 50 条

[21] Generic imatinib in the treatment of chronic myeloid leukemia: Cerrahpasa experience
Eskazan, Ahmet Emre
Soysal, Teoman
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2016, 22 (02) : 382 - 384
[22] Treatment selection after imatinib resistance in chronic myeloid leukemia
Jabbour, Elias
Cortes, Jorge
Kantarjian, Hagop
TARGETED ONCOLOGY, 2009, 4 (01) : 3 - 10
[23] Criteria and treatment of insufficient responses to imatinib in chronic myeloid leukemia
Rousselot, Philippe
HEMATOLOGIE, 2006, 12 : 19 - 25
[24] Chronic myeloid leukemia in the imatinib era
Druker, BJ
SEMINARS IN HEMATOLOGY, 2003, 40 (02) : 1 - 3
[25] Imatinib in Chronic Myeloid Leukemia: an Overview
Sacha, Tomasz
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2014, 6 (01)
[26] Imatinib in chronic myeloid leukemia - Reply
Druker, Brian
Gathmann, Insa
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (17): : 1780 - 1780
[27] Imatinib Mesylate in Chronic Myeloid Leukemia
Mishra, Pravas
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 5 - 6
[28] Imatinib therapy in chronic myeloid leukemia
Crossman, LC
O'Brien, SG
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (03) : 605 - +
[29] Chronic myeloid leukemia: current treatment options
Goldman, JM
Druker, BJ
BLOOD, 2001, 98 (07) : 2039 - 2042
[30] Current perspectives for the treatment of chronic myeloid leukemia
Aladag, Elifcan
Haznedaroglu, Ibrahim Celalettin
TURKISH JOURNAL OF MEDICAL SCIENCES, 2019, 49 (01) : 1 - 10

← 1 2 3 4 5 →